Serina Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Serina Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Serina Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 96.1 %.
  • Serina Therapeutics, Inc. annual Return On Equity for 2023 was 43.2 %, a 19.7% decline from 2022.
  • Serina Therapeutics, Inc. annual Return On Equity for 2022 was 53.8 %, a 43.8% decline from 2021.
  • Serina Therapeutics, Inc. annual Return On Equity for 2021 was 95.7 %, a 74.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.